China Hastens New Drug Development, Bayer Starts 20 New Clinical Trials
This article was originally published in PharmAsia News
Executive Summary
Bayer HealthCare China President Li Xilie, revealed April 28 that Bayer Schering Pharma started 20 new drug clinical trials in China last year